1. Home
  2. RGCO vs GNFT Comparison

RGCO vs GNFT Comparison

Compare RGCO & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGCO
  • GNFT
  • Stock Information
  • Founded
  • RGCO 1912
  • GNFT 1999
  • Country
  • RGCO United States
  • GNFT France
  • Employees
  • RGCO N/A
  • GNFT N/A
  • Industry
  • RGCO Oil & Gas Production
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RGCO Utilities
  • GNFT Health Care
  • Exchange
  • RGCO Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • RGCO 223.4M
  • GNFT 209.2M
  • IPO Year
  • RGCO N/A
  • GNFT 2019
  • Fundamental
  • Price
  • RGCO $20.55
  • GNFT $4.51
  • Analyst Decision
  • RGCO
  • GNFT Strong Buy
  • Analyst Count
  • RGCO 0
  • GNFT 1
  • Target Price
  • RGCO N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • RGCO 9.3K
  • GNFT 10.0K
  • Earning Date
  • RGCO 05-06-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • RGCO 4.04%
  • GNFT N/A
  • EPS Growth
  • RGCO N/A
  • GNFT N/A
  • EPS
  • RGCO 1.29
  • GNFT 0.03
  • Revenue
  • RGCO $91,314,087.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • RGCO $10.87
  • GNFT $15.98
  • Revenue Next Year
  • RGCO $3.26
  • GNFT N/A
  • P/E Ratio
  • RGCO $15.90
  • GNFT $145.64
  • Revenue Growth
  • RGCO 9.74
  • GNFT 105.01
  • 52 Week Low
  • RGCO $19.05
  • GNFT $2.55
  • 52 Week High
  • RGCO $24.20
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • RGCO 44.07
  • GNFT 63.33
  • Support Level
  • RGCO $20.53
  • GNFT $4.22
  • Resistance Level
  • RGCO $21.36
  • GNFT $4.39
  • Average True Range (ATR)
  • RGCO 0.70
  • GNFT 0.21
  • MACD
  • RGCO -0.10
  • GNFT -0.00
  • Stochastic Oscillator
  • RGCO 13.59
  • GNFT 93.09

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: